Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma

NCT04946318 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

136

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Asthma

Interventions

DRUG: CSJ117
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals